Translational Immunology, Osteoimmunology & Immunoporosis Lab
(TIOIL) 

Dr. Rupesh K. Srivastava is an Associate Professor, Department of Biotechnology, AIIMS and also an Adjunct Faculty (CCRF,AIIMS), New Delhi. He is a translational researcher and academician with expertise in Cellular and Molecular Immunology. He obtained his Ph.D. from National Centre for Cell Science (NCCS), Pune, India and post-doctoral training at both Columbia University Medical Centre, New York and Roswell Park Cancer Institute, New York, USA. Dr. Srivastava is an Elected Executive Committee Member (2022-24) of the Indian Immunology Society (IIS). He is credited with discovering the pivotal role of the immune system in the pathophysiology of osteoporosis, a novel field proposed by him as “Immunoporosis” (Immunology of Osteoporosis). His Translational Immunology, Osteoimmunology, and Immunoporosis Lab (TIOIL) at AIIMS is actively involved in deciphering the cellular and molecular interactions between the Immune and Bone systems under both healthy and diseased conditions.

Dr. Srivastava is the recipient of the Prof. G. P. Talwar Gold Medal-2024 (ISSRF); TETCs-Best Published Research Paper Award-2023, AIIMS Research Excellence Award-2022 & 2023, the prestigious “G. P. Talwar Young Scientist Award”- TWICE (IIS-2011 and ISSRF-2019), and Science Communicator Award-2017. He is also a GOLD Medallist (08) during his Master’s. He has executed/currently handling more than 20 major research projects (>24Cr) funded by national agencies such as Wecome Trust, DBT, DST, ICMR, CCRH-AYUSH, and AIIMS, along with several MOUs with International Universities and Industries. Dr. Srivastava has >100 peer-reviewed international publications with H-index of 26, i10 index of 47, with >2790 citations and a cumulative impact factor >650. He has supervised numerous PhD, DM, MD and M.Sc. students. He has an ongoing Clinical Trial Research Grant from ICMR, on probiotics as a therapy for osteoporosis impacting various national health initiatives.